(IPAR) Inter Parfums - NASDAQ
Sector: Consumer Defensive | Industry: Household & Personal Products | Exchange: NASDAQ (USA) | Market Cap: 3.260m USD | Total Return: -24.1% in 12m
Avg Turnover: 21.2M
EPS Trend: 71.8%
Qual. Beats: 2
Rev. Trend: 94.2%
Qual. Beats: 0
Warnings
Extended 1w
Tailwinds
No distinct edge detected
Inter Parfums, Inc. (IPAR) specializes in the development, manufacture, and global distribution of prestige fragrances and cosmetics. The company operates through a licensing model, where it secures long-term exclusive rights to produce and market scents for established luxury and fashion houses, including Montblanc, Coach, and Jimmy Choo.
The business is organized into European and United States segments, utilizing a multi-channel distribution network that spans department stores, travel retail, and e-commerce. In the personal care sector, fragrance companies often benefit from high brand loyalty and significant margins, though they remain sensitive to discretionary consumer spending and global travel trends. For a deeper look into these financial drivers, ValueRay provides additional analytical tools.
Founded in 1982 and headquartered in New York, the company manages a diverse portfolio that includes both owned trademarks and licensed brands. This structure allows IPAR to scale its production across various price points and geographic markets while minimizing the capital risks associated with building new brands from scratch.
- Global prestige fragrance demand sustains high-margin revenue growth across core luxury brands
- Strategic licensing acquisitions like Lacoste and Roberto Cavalli expand market share potential
- Supply chain efficiency and raw material costs impact quarterly operating profit margins
- Travel retail recovery and duty-free volume drive international segment sales performance
- Brand concentration risk remains high with Montblanc and Jimmy Choo driving results
| Net Income: 169.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -0.11 > 1.0 |
| NWC/Revenue: 46.29% < 20% (prev 41.21%; Δ 5.08% < -1%) |
| CFO/TA 0.14 > 3% & CFO 222.3m > Net Income 169.3m |
| Net Debt (-33.5m) to EBITDA (294.5m): -0.11 < 3 |
| Current Ratio: 3.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.0m) vs 12m ago -0.45% < -2% |
| Gross Margin: 63.96% > 18% (prev 64.13%; Δ -0.18% > 0.5%) |
| Asset Turnover: 100.2% > 50% (prev 101.9%; Δ -1.65% > 0%) |
| Interest Coverage Ratio: 37.74 > 6 (EBIT TTM 269.4m / Interest Expense TTM 7.14m) |
| A: 0.45 (Total Current Assets 997.8m - Total Current Liabilities 305.9m) / Total Assets 1.54b |
| B: 0.55 (Retained Earnings 846.6m / Total Assets 1.54b) |
| C: 0.18 (EBIT TTM 269.4m / Avg Total Assets 1.49b) |
| D: 2.05 (Book Value of Equity 881.6m / Total Liabilities 430.2m) |
| Altman-Z'' = 8.10 = AAA |
| DSRI: 1.10 (Receivables 346.4m/308.7m, Revenue 1.49b/1.47b) |
| GMI: 1.00 (GM 64.13% / 63.96%) |
| AQI: 0.92 (AQ_t 0.22 / AQ_t-1 0.24) |
| SGI: 1.02 (Revenue 1.49b / 1.47b) |
| TATA: -0.03 (NI 169.3m - CFO 222.3m) / TA 1.54b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of June 15, 2026, the stock is trading at USD 101.78 with a total of 239,302 shares traded.
Over the past week, the price has changed by +11.52%,
over one month by +16.03%,
over three months by +11.60% and
over the past year by -24.08%.
Inter Parfums has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy IPAR.
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 109.3 | 7.4% |
P/E Trailing = 19.3131
P/E Forward = 21.4592
P/S = 2.1809
P/B = 3.6972
P/EG = 3.1987
Revenue TTM = 1.49b USD
EBIT TTM = 269.4m USD
EBITDA TTM = 294.5m USD
Long Term Debt = 107.2m USD (from longTermDebt, last quarter)
Short Term Debt = 61.0m USD (from shortTermDebt, last quarter)
Debt = 203.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 20.8m
Net Debt = -33.5m USD (calculated: Debt 203.6m - CCE 237.1m)
Enterprise Value = 3.23b USD (3.26b + Debt 203.6m - CCE 237.1m)
Interest Coverage Ratio = 37.74 (Ebit TTM 269.4m / Interest Expense TTM 7.14m)
EV/FCF = 16.21x (Enterprise Value 3.23b / FCF TTM 199.0m)
FCF Yield = 6.17% (FCF TTM 199.0m / Enterprise Value 3.23b)
FCF Margin = 13.31% (FCF TTM 199.0m / Revenue TTM 1.49b)
Net Margin = 11.33% (Net Income TTM 169.3m / Revenue TTM 1.49b)
Gross Margin = 63.96% ((Revenue TTM 1.49b - Cost of Revenue TTM 538.7m) / Revenue TTM)
Gross Margin QoQ = 65.13% (prev 61.46%)
Tobins Q-Ratio = 2.09 (Enterprise Value 3.23b / Total Assets 1.54b)
Interest Expense / Debt = 3.51% (Interest Expense 7.14m / Debt 203.6m)
Taxrate = 23.28% (63.7m / 273.6m)
NOPAT = 206.7m (EBIT 269.4m * (1 - 23.28%))
Current Ratio = 3.26 (Total Current Assets 997.8m / Total Current Liabilities 305.9m)
Debt / Equity = 0.23 (Debt 203.6m / totalStockholderEquity, last quarter 881.6m)
Debt / EBITDA = -0.11 (Net Debt -33.5m / EBITDA 294.5m)
Debt / FCF = -0.17 (Net Debt -33.5m / FCF TTM 199.0m)
Total Stockholder Equity = 868.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.35% (Net Income 169.3m / Total Assets 1.54b)
RoE = 19.50% (Net Income TTM 169.3m / Total Stockholder Equity 868.2m)
RoCE = 27.62% (EBIT 269.4m / Capital Employed (Equity 868.2m + L.T.Debt 107.2m))
RoIC = 16.90% (NOPAT 206.7m / Invested Capital 1.22b)
WACC = 6.92% (E(3.26b)/V(3.46b) * Re(7.18%) + D(203.6m)/V(3.46b) * Rd(3.51%) * (1-Tc(0.23)))
Discount Rate = 7.18% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -48.89 | Cagr: -0.12%
[DCF] Terminal Value 76.23% ; FCFF base≈194.3m ; Y1≈205.2m ; Y5≈240.4m
[DCF] Fair Price = 116.6 (EV 3.70b - Net Debt -33.5m = Equity 3.73b / Shares 32.0m; r=8.35% [WACC [floored]]; 5y FCF grow 6.22% → 2.50% )
EPS Correlation: 71.76 | EPS CAGR: 5.90% | SUE: 0.95 | # QB: 2
Revenue Correlation: 94.24 | Revenue CAGR: 7.19% | SUE: -0.71 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.00 | Chg30d=-0.17% | Revisions=-20% | Analysts=4
EPS next Quarter (2026-09-30): EPS=1.80 | Chg30d=+2.67% | Revisions=-33% | Analysts=4
EPS current Year (2026-12-31): EPS=4.86 | Chg30d=+0.25% | Revisions=-50% | GrowthEPS=-7.3% | GrowthRev=+0.4%
EPS next Year (2027-12-31): EPS=5.57 | Chg30d=+0.25% | Revisions=-25% | GrowthEPS=+14.7% | GrowthRev=+6.6%
[Analyst] Revisions Ratio: -50%